FMR LLC 13D/13G Filings for Nektar Therapeutics (NKTR)

FMR LLC 13D and 13G filings for Nektar Therapeutics:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-09
09:22 am
Sale
2022-02-0813GNEKTAR THERAPEUTICS
NKTR
FMR LLC450,614
3.662%
-180,440decrease
(-28.59%)
Filing
2021-12-10
08:52 am
Sale
2021-12-0913GNEKTAR THERAPEUTICS
NKTR
FMR LLC631,054
5.128%
-632,258decrease
(-50.05%)
Filing